Discover

TVGN
Tevogen Bio Holdings Inc.
4.06
1 x 3.52
1 x 4.72
bid
ask
+
0.17
4.37%
1 @ 04:00 PM
4.14 +0.08 (1.97%)
Ytd-75.48%
1y-92.68%
3.77
day range
4.16
3.64
52 week range
70.00
Open3.85Prev Close3.89Low3.77High4.16Mkt Cap17.13M
Vol17.36KAvg Vol27.13KEPS-2.87P/E-1.41Forward P/EN/A
Beta0.20Short Ratio0.09Inst. Own3.82%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg7.90200-d Avg14.681yr Est4.20

TVGN News

Tevogen Bio Announces 2026 Annual Meeting of Stockholders
globenewswire.com
Tevogen Bio Announces 2026 Annual Meeting of Stockholders

WARREN, N.J., July 13, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday&

Tevogen Announces Formation of a Healthcare Services Initiative
globenewswire.com
Tevogen Announces Formation of a Healthcare Services Initiative

William Keane Appointed Interim Head of Initiative, Evaluating Potential Management Services Organiz

Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
globenewswire.com
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Mill

WARREN, N.J., May 28, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (N

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
globenewswire.com
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organizati

WARREN, N.J., May 21, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (N

Letter to Shareholders from CEO Dr. Ryan Saadi
globenewswire.com
Letter to Shareholders from CEO Dr. Ryan Saadi

Tevogen highlights improved operating performance, disciplined capital allocation, pipeline growth,

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
globenewswire.com
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Cl

WARREN, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (N

Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
globenewswire.com
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Inte

WARREN, N.J., April 27, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
globenewswire.com
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Driv

Potential transaction expected to add $20M+ in revenue and support double-digit growth, further stre

Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
globenewswire.com
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement

WARREN, N.J., March 25, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)

Tevogen Bio (TVGN) to Release Quarterly Earnings on Wednesday
defenseworld.net
Tevogen Bio (TVGN) to Release Quarterly Earnings on Wednesday

Tevogen Bio (NASDAQ: TVGN - Get Free Report) will likely be releasing its results before the market

Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
globenewswire.com
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (F

WARREN, N.J., March 18, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)

Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
globenewswire.com
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Ut

Tevogen highlights capital discipline, minimal share use, strong insider ownership, and potential ac

Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
globenewswire.com
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Ex

WARREN, N.J., March 13, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)

Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
globenewswire.com
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness M

WARREN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)

BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com
BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Sessi

U.S. stock futures lower, with Dow futures down over 1%. BETA Technologies (NYSE: BETA) fell in pre-

Tevogen Names Leadership Team to Execute Diversified Growth Strategy
globenewswire.com
Tevogen Names Leadership Team to Execute Diversified Growth Strategy

WARREN, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)

Letter to Shareholders from CEO Dr. Ryan Saadi
globenewswire.com
Letter to Shareholders from CEO Dr. Ryan Saadi

WARREN, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)

Tevogen Bio Explores Buyout To Boost Generics Platform
benzinga.com
Tevogen Bio Explores Buyout To Boost Generics Platform

Tevogen Bio Holdings (NASDAQ: TVGN) shares are wobbling on Friday as the company is advancing its ge

Marvell Technology, Day One Biopharmaceuticals, Samsara And Other Big Stocks Moving Higher On Friday
benzinga.com
Marvell Technology, Day One Biopharmaceuticals, Samsara And Other Big Stocks Moving Higher On Friday

Dow Jones falls 500 points on Friday, Marvell Technology shares jump 18.4%, other stocks recording g

Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical
globenewswire.com
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apoz

WARREN, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)

Tevogen Announces Reverse Stock Split
globenewswire.com
Tevogen Announces Reverse Stock Split

WARREN, N.J., March 04, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
globenewswire.com
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization

WARREN, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session